KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update

KORU Medical Systems, Inc. (NASDAQ:KRMD) saw a large drop in short interest in October. As of October 15th, there was short interest totaling 846,900 shares, a drop of 29.4% from the September 30th total of 1,200,000 shares. Currently, 1.9% of the shares of the company are sold short. Based on an average daily volume of 97,200 shares, the short-interest ratio is currently 8.7 days. Based on an average daily volume of 97,200 shares, the short-interest ratio is currently 8.7 days. Currently, 1.9% of the shares of the company are sold short.

KORU Medical Systems Stock Performance

Shares of KRMD stock traded down $0.12 during trading hours on Monday, hitting $3.84. The company’s stock had a trading volume of 43,065 shares, compared to its average volume of 172,071. The company has a 50 day moving average of $4.05 and a 200 day moving average of $3.55. The stock has a market cap of $177.54 million, a PE ratio of -42.67 and a beta of 0.49. The company has a current ratio of 2.91, a quick ratio of 2.25 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a 12-month low of $1.86 and a 12-month high of $5.05.

KORU Medical Systems (NASDAQ:KRMD) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.04. The business had revenue of $10.20 million for the quarter, compared to the consensus estimate of $9.46 million. KORU Medical Systems had a negative net margin of 12.24% and a negative return on equity of 26.77%. On average, sell-side analysts forecast that KORU Medical Systems will post -0.13 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, KORU Medical Systems has an average rating of “Moderate Buy” and a consensus price target of $4.63.

Institutional Trading of KORU Medical Systems

Large investors have recently made changes to their positions in the business. Calamos Advisors LLC lifted its stake in shares of KORU Medical Systems by 36.5% in the 1st quarter. Calamos Advisors LLC now owns 88,718 shares of the company’s stock valued at $225,000 after purchasing an additional 23,729 shares during the period. Connor Clark & Lunn Investment Management Ltd. lifted its stake in shares of KORU Medical Systems by 11.8% in the 1st quarter. Connor Clark & Lunn Investment Management Ltd. now owns 66,917 shares of the company’s stock valued at $170,000 after purchasing an additional 7,046 shares during the period. HighTower Advisors LLC lifted its stake in shares of KORU Medical Systems by 18.4% in the 1st quarter. HighTower Advisors LLC now owns 51,400 shares of the company’s stock valued at $131,000 after purchasing an additional 8,000 shares during the period. Russell Investments Group Ltd. lifted its stake in shares of KORU Medical Systems by 220.5% in the 1st quarter. Russell Investments Group Ltd. now owns 214,908 shares of the company’s stock valued at $546,000 after purchasing an additional 147,857 shares during the period. Finally, OMERS ADMINISTRATION Corp acquired a new position in shares of KORU Medical Systems in the 1st quarter valued at $239,000. 58.60% of the stock is owned by hedge funds and other institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.